NPK76-II-72-1

response biomarkers — cross-omics
Drug responseDRUG → SHRNACell line

Across CCLE and GDSC cell-line panels, response to NPK76-II-72-1 is significantly associated with the shRNA dependency of multiple gene dependencies, with BONE cell lines showing a particularly strong set of associations.

The most reproducible NPK76-II-72-1 response-associated gene dependencies across cancer lineages are FIGNL2, CHRNB3, and FES, each associated with drug response in up to 8 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.

Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, NPK76-II-72-1 response versus FIGNL2 shRNA dependency in BONE (Pearson r = 0.77).

Shrna dependency biomarkers of NPK76-II-72-1 response

Ranked by combined sampling and lineage consensus. X-score (response→biomarker) and Y-score (biomarker→response) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner gene dependencieX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BONEFIGNL2 →+0.276+1.274.035.03337
STOMACHCHRNB3 →+0.196+0.907.001.00537
LARGE_INTESTINEFES →-0.191-0.864.001.00237
SOFT_TISSUEDPH1 →+0.375+1.014.048.00328
CNSCDH24 →+0.161+0.650.043.00937
BLOOD_LymphomaCYP46A1 →+0.436+0.999.016.00836
Each biomarker links to its Q-omics profile. Showing the 6 strongest associations by consensus.

NPK76-II-72-1 response vs FIGNL2 — BONE

Per-cell-line scatter of NPK76-II-72-1 response vs FIGNL2 shRNA dependency in BONE.

Explore this scatter interactively →

Exploration